Factors to predict recurrence of atrial fibrillation in patients with hypertension

Clinical Cardiology

Volumn 32, Issue 5, 2009, Pages 264-268

  Ma, XiaoJing ^a   Zhang, XingHua ^a   Guo, WenBin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SINUS RHYTHM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS AS TOPIC;

EID: 66249083817     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20449     Document Type: Article

References (22)

1. Sundstrom J, Sullivan L, D'Agostino RB, Jacques PF, Selhub J, et al.: Plasma homocysteine, hypertension incidence, and blood pressure tracking: The Framingham Heart Study. Hypertension. 2003;42:1100-1105. (Pubitemid 37549062)
2. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE: The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98:476-484.
3. Zapolski T, Wysokinski A: Stunning of the left atrium after pharmacological cardioversion of atrial fibrillation. Kardiol Pol. 2005;63:254-262. (Pubitemid 41416102)
4. Savelieva I, Camm J: Update on atrial fibrillation: Part I. Clin Cardiol. 2008;31:55-62.
5. Donal E, Herpin D: Atrial remodeling, systemic hypertension, stroke. Arch Mal Coeur Vaiss. 2005;98:53-57.
6. Nitta T, Ishii Y, Miyagi Y, Ohmori H, Sakamoto S, et al.: Concurrent multiple left atrial focal activations with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in atrial fibrillation. J Thorac Cardiovasc Surg. 2004;127:770-778. (Pubitemid 38316183)
7. Boriani G, Diemberger I, Biffi M, Camanini C, Valzania C, et al.: P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. Int J Cardiol. 2005;101:355-361. (Pubitemid 40723622)
8. Yilmaz R, Demirbag R: P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol. 2005;38:279-284. (Pubitemid 40898316)
9. Celik T, Iyisoy A, Kursaklioglu H, Yilmaz MI, Kose S, et al.: The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: A randomized clinical study. Clin Cardiol. 2005;28:298-302. (Pubitemid 40803516)
10. Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, et al.; ACUTE Investigators: Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol. 2005;96:935-941. (Pubitemid 41363763)
11. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H: Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol. 2005;45:1807-1812. (Pubitemid 40789939)
12. Srichai MB, Griffin B, Banbury M, Sabik EM: Images in cardiovascular medicine. Inverted left atrial appendage ligation mimicking thrombus. Circulation. 2005;111:e178-e179.
13. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, et al.: Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation. 2004;110:1042-1046. (Pubitemid 39319000)
14. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, et al.: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol. 1994;74:236-241. (Pubitemid 24239044)
15. Donal E, Yamada H, Leclercq C, Herpin D: The left atrial appendage, a small, blind-ended structure: A review of its echocardiographic evaluation and its clinical role. Chest. 2005;128:1853-1862. (Pubitemid 41324484)
16. Dudley SC Jr, Hoch NE, McCann LA, Honeycutt C, Diamandopoulos L, et al.: Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: Role of the NADPH and xanthine oxidases. Circulation. 2005;112:1266-1273. (Pubitemid 41268651)
17. Barbato G, Carinci V, Pergolini F, Di Pasquale G: Percutaneous occlusion of the left atrial appendage for systemic embolism prevention in patients with atrial fibrillation: state of the art and report of two cases. Ital Heart J. 2005;6:409-413.
18. Dogan A, Kahraman H, Ozturk M, Avsar A: P wave dispersion and left atrial appendage function for predicting recurrence after conversion of atrial fibrillation and relation of p wave dispersion to appendage function. Echocardiography. 2004;21 523-530. (Pubitemid 39071436)
19. Kinay O, Nazli C, Ergene O, Dogan A, Gedikli O, et al.: Time interval from the initiation of the electrocardiographic P wave to the start of left atrial appendage ejection flow: A novel method for predicting atrial fibrillation recurrence. J Am Soc Echocardiogr. 2002;15:1479-1484. (Pubitemid 36519670)
20. Weiss JN, Qu Z, Chen PS, Lin SF, Karagueuzian HS, et al.: The dynamics of cardiac fibrillation. Circulation. 2005;112:1232-1240. (Pubitemid 41216132)
21. O'Hara GE, Charbonneau L, Chandler M, Vidaillet HJ Jr, Philippon F, et al.; AFFIRM Investigators: Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). Am J Cardiol. 2005;96:815-821. (Pubitemid 41317657)
22. Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, et al.: Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 2000;75:790-795. (Pubitemid 30640636)